Main Article Content
Background Mothers of premature newborns often have difficulty giving adequate breast milk volume to their infants. Domperidone is an antagonist of peripheral dopamine receptors and believed to increase breast milk production. In Indonesia, no study has been done to date on the effect of domperidone on maternal milk production in mothers of premature newborns.
Objective To evaluate the effect of domperidone on milk production in mothers of premature newborns who failed to lactate.
Methods A randomized controlled trial was conducted from July to December 2012 in the Perinatology Unit, Haji Adam Malik Hospital, Medan. Mothers of premature newborns were given lactation counseling for 7 days in order to increase their milk production. Mothers who failed to lactate after that time were enrolled in the study. Fifty subjects were assigned to receive either domperidone or a placebo for 7 days. Milk volume was measured every 2 hours (from 7 am to 9 pm), in the 24 hours before starting therapy, and on the 7th and 10th days (the 10th day being 3 days after stopping therapy).
Results This study involved 25 mothers in the domperidone groups and 25 others in placebo group. After 7 days of therapy, mean breast milk volume was significantly higher in the domperidone group than in the placebo group [181.6 (SD 80.2) vs. 72.4 (SD 57.8) mL, respectively; 95%CI of differences 69.36 to 148.93; P=0.0001]. At day 10, breast milk production remained significantly higher in the domperidone group. Furthermore, in the domperidone group, no significant difference in mean breast milk volumes was noted between the 7th and 10th days (P=0.65).
Conclusion In mothers of premature newborns who failed to lactate, domperidone therapy for 7 days causes significantly higher milk production compared to placebo.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr. 2010;156:S3-7.
3. da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ. 2001;164:17-21.
4. Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Allen M, Dooley KC. Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk. BMC Pregnancy Childbirth. 2006;6:17. doi: 10.1186/1471-2393-6-17.
5. da Silva OP, Knoppert DC. Domperidone for lactating women. CMAJ. 2004;171:725-6.
6. Hartmann PE, Cregan MD, Ramsay DT, Simmer K, Kent JC. Physiology of lactation in preterm mothers: initiation and maintenance. Pediatr Ann. 2003;32:351-8.
7. Osadchy A, Moretti M, Koren G. Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Int. 2012;2012:642893. doi: 10.1155/2012/642893.
8. Asztalos EV, Campbell-Yeo M, daSilva OP, Kiss A, Knoppert DC, Ito S. Enhancing breast milk production with domperidone in mothers of preterm neonates (EMPOWER trial). BMC Pregnancy Childbirth. 2012;12:87. doi: 10.1186/1471-2393-12-87.
9. Albright LM. Domperidone in lactation: use as a galactogogue. Int J Pharm Compd. 2004;8:329-35.
10. Wan EW, Davey K, Page-Sharp M, Hartmann PE, Simmer K, Ilett KF. Dose-effect study of domperidone as a galactogogue in preterm mothers with insufficient milk supply, and its transfer into milk. Br J Clin Pharmacol. 2008;66:283-9.
11. Henderson A. Domperidone. Discovering new choices for lactating mothers. Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) Lifelines. 2003;7:54-60.
12. Jones W, Breward S. Use of domperidone to enhance lactation: what is the evidence? Community Pract. 2011;84:35-7.
13. Knoppert DC, Page A, Warren J, Seabrook JA, Carr M, Angelini M, et al. The effect of two different domperidone doses on maternal milk production. J Hum Lact. 2013;29:38-44.
14. Petraglia F, De Leo V, Sardelli S, Pieroni ML, D’Antona N, Genazzani AR. Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol. 1985;19:281-7.
15. Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Caddell K, Allen VM, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics. 2010;125:e107-14.
16. US Food and Drug Administration. FDA cautions breast-feeding moms. FDA Consum. 2004;38:6.
17. Bozzo P, Koren G, Ito S. Health Canada advisory on domperidone. Should I avoid prescribing domperidone to women to increase milk production? Can Fam Physician. 2012;58:952-3.